WallStreetZenWallStreetZen

NYSE: CC
Chemours Co Stock

Overview
ForecastEarningsRevenueDividendOwnership
$12.49+0.15 (+1.22%)
Updated Apr 29, 2025
CC Price
$12.49
Fair Value Price
N/A
Market Cap
$1.87B
52 Week Low
$9.33
52 Week High
$29.21
P/E
21.53x
P/B
3.09x
P/S
0.44x
PEG
0.23x
Dividend Yield
8.01%
Revenue
$5.78B
Earnings
$86.00M
Gross Margin
19.9%
Operating Margin
6.76%
Profit Margin
1.5%
Debt to Equity
11.44
Operating Cash Flow
-$633M
Beta
1.62
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CC Overview

The Chemours Company manufactures performance chemicals. Its segments include Titanium Technologies (titanium dioxide), Fluoroproducts (refrigerants and industrial fluoropolymer resins and derivatives including Freon, Teflon, Viton, Nafion, ECCtreme ECA, and Krytox), and Chemical Solutions (cyanide, sulfuric acid, aniline, methylamines, and reactive metals). Spun off from DuPont in 2015, Chemours is headquartered in Wilmington, DE.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CC's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

C
Value
C
Growth
D
Momentum
D
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Specialty Chemical

Industry Rating
C
CC
Ranked#29 of 52

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Ingevity (NGVT)
$33.03A
Oil Dri Of America (ODC)
$42.00B
Perimeter Solutions (PRM)
$10.24B
View Top Specialty Chemical Stocks

Be the first to know about important CC news, forecast changes, insider trades & much more!

CC News

Overview

Due Diligence Score

–
Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CC scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CC ($12.49) is trading below its intrinsic value of $22.84, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CC is good value based on its earnings relative to its share price (21.53x), compared to the US market average (29.19x)
P/E vs Market Valuation
CC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CC due diligence checks available for Premium users.

Valuation

CC price to earnings (PE)

For valuing profitable companies with steady earnings

Company
21.53x
Industry
27.8x
Market
29.19x
CC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

CC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
3.09x
Industry
3.18x
CC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CC price to earnings growth (PEG)

For valuing profitable companies with growth potential

CC is good value based... subscribe to Premium to read more.
PEG Value Valuation

CC's financial health

Profit margin

Revenue
$1.4B
Net Income
-$8.0M
Profit Margin
-0.6%
CC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$7.5B
Liabilities
$6.9B
Debt to equity
11.44
CC's short-term assets ($3.03B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CC's long-term liabilities ($5.11B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CC's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$138.0M
Investing
-$107.0M
Financing
$85.0M
CC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CC vs Specialty Chemical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CCC$1.87B+1.22%21.53x3.09x
KWRC$1.87B+0.78%16.28x1.38x
MTXC$1.62B+0.24%-68.07x1.01x
PRMB$1.53B+0.79%-256.00x1.32x
IOSPC$2.24B+0.11%62.87x1.85x
View Top Specialty Chemical Stocks

Chemours Co Stock FAQ

What is Chemours Co's quote symbol?

(NYSE: CC) Chemours Co trades on the NYSE under the ticker symbol CC. Chemours Co stock quotes can also be displayed as NYSE: CC.

If you're new to stock investing, here's how to buy Chemours Co stock.

What is the 52 week high and low for Chemours Co (NYSE: CC)?

(NYSE: CC) Chemours Co's 52-week high was $29.21, and its 52-week low was $9.33. It is currently -57.24% from its 52-week high and 33.87% from its 52-week low.

How much is Chemours Co stock worth today?

(NYSE: CC) Chemours Co currently has 149,440,788 outstanding shares. With Chemours Co stock trading at $12.49 per share, the total value of Chemours Co stock (market capitalization) is $1.87B.

Chemours Co stock was originally listed at a price of $20.85 in Jun 19, 2015. If you had invested in Chemours Co stock at $20.85, your return over the last 9 years would have been -40.1%, for an annualized return of -5.54% (not including any dividends or dividend reinvestments).

How much is Chemours Co's stock price per share?

(NYSE: CC) Chemours Co stock price per share is $12.49 today (as of Apr 29, 2025).

What is Chemours Co's Market Cap?

(NYSE: CC) Chemours Co's market cap is $1.87B, as of Apr 30, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Chemours Co's market cap is calculated by multiplying CC's current stock price of $12.49 by CC's total outstanding shares of 149,440,788.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.